z-logo
open-access-imgOpen Access
Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure
Author(s) -
Fatih Güzelbulut,
Ekrem Aslan,
Ayça Gökçen Değirmenci Saltürk,
Özgür Bahadır,
Halil Şahin,
Mevlüt Kıyak,
Emine Kanatsız,
Mustafa Keçeci
Publication year - 2019
Publication title -
the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2019.18
Subject(s) - medicine , dasabuvir , ombitasvir , ribavirin , paritaprevir , ritonavir , chronic hepatitis , hepatitis c , virology , human immunodeficiency virus (hiv) , virus , viral load , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom